Intralesional chemotherapy for Kaposi's sarcoma

L. Brambilla, V. Boneschi, G. Beretta, A. F. Finzi

Research output: Contribution to journalArticlepeer-review


Over a period of 36 months we treated 12 patients with skin localizations of Kaposi's sarcoma with intralesional chemotherapy. Local administration of vincristine (usual dose 0.1 mg per site) or bleomycin appeared to be very effective: in 93 injected nodules we obtained 74 complete and 19 partial regressions. No significant local or systemic toxicity has so far been observed.

Original languageEnglish
Pages (from-to)150-155
Number of pages6
Issue number3
Publication statusPublished - 1984

ASJC Scopus subject areas

  • Dermatology


Dive into the research topics of 'Intralesional chemotherapy for Kaposi's sarcoma'. Together they form a unique fingerprint.

Cite this